Total item
Cart Subtotal
$0.00 - Oguri G, .et al. Effects of methylglyoxal on human cardiac fibroblast: roles of transient receptor potential ankyrin 1 (TRPA1) channels., Am J Physiol Heart Circ Physiol., 2014, 307(9):H1339-52 PMID: 25172898
Biological Activity
LY2157299 is an orally active transforming growth factor beta receptor (TGF-βR) kinase inhibitor.
Targets
| TβRI (Cell-free assay) | ||||
| 56 nM |
| In vitro | DMSO | 74 mg/mL (200.31 mM) | |
| Water | <1 mg/mL (<1 mM) | ||
| Ethanol | <1 mg/mL (<1 mM) | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 27.07 mL | 135.35 mL | 270.71 mL |
| 0.5 mM | 5.41 mL | 27.07 mL | 54.14 mL |
| 1 mM | 2.71 mL | 13.54 mL | 27.07 mL |
| 5 mM | 0.54 mL | 2.71 mL | 5.41 mL |
*The above data is based on the productmolecular weight 369.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A11017 |
|---|---|
| Actions | Inhibitor |
| M. Wt | 369.4 |
| Formula | C22H19N5O |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 700874-72-2 |
| Synonyms | LY-2157299 |
| SMILES | CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy LY2157299 | LY2157299 Supplier | purchase | cost | manufacturer | order | distributor | buy 700874-72-2| 700874-72-2 Supplier | purchase 700874-72-2 | 700874-72-2 cost | 700874-72-2 manufacturer | order 700874-72-2 | 700874-72-2 distributor
Adooq Quality Guarantee
We promise all products perform as described.